These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35915218)

  • 1. Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells.
    Huang MB; Brena D; Wu JY; Roth WW; Owusu S; Bond VC
    Sci Rep; 2022 Aug; 12(1):13204. PubMed ID: 35915218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.
    Huang MB; Wu JY; Lillard J; Bond VC
    Oncotarget; 2019 Sep; 10(52):5419-5438. PubMed ID: 31534628
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB; Gonzalez RR; Lillard J; Bond VC
    Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.
    Shelton MN; Huang MB; Ali SA; Powell MD; Bond VC
    J Virol; 2012 Jan; 86(1):406-19. PubMed ID: 22013042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
    Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
    BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide targets EGFR to impede epithelial-mesenchymal transition in human breast cancer cells.
    Kaewpiboon C; Boonnak N; Salae AW; Pakdeepromma S; Yawut N; Chung YH
    J Pharm Biomed Anal; 2024 Sep; 248():116267. PubMed ID: 38889579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
    Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
    Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
    Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
    Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
    Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation.
    Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY
    Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.